Brexit update: trade marks and domain names

ARTICLE SUMMARY

With the withdrawal agreement ratified in late 2019, the UK formally left the European Union on 31 January 2020, entering an additional 11 month transition period.

authors
No items found.
Related Services
Related Industries

With the withdrawal agreement ratified in late 2019, the UK formally left the European Union on 31 January 2020, entering an additional 11 month transition period.

With the withdrawal agreement ratified in late 2019, the UK formally left the European Union on 31 January 2020, entering an additional 11 month transition period.

While this brings about changes for the UK's relationship with Europe, your relationship with Potter Clarkson will not change in any way. It will not disrupt the services we provide to you - it is business as usual. As a pan-European intellectual property law firm, with offices in multiple EU-member states, our ability to support clients in all aspects of IP is completely unaffected by any Brexit-related changes.

With many clients facing uncertainty surrounding Brexit and with the deadline of 31 December 2020 fast approaching, we have set out below the position as it currently stands, along with our recommendations to ensure trade mark rights and domain names remain protected.

UK national trade mark rights

UK national trade mark rights will be unaffected by the UK's departure from the EU. This means that any trade marks, including International or Madrid Protocol Trade Mark Registrations (WIPO) that design

Related News

Combination therapies: IP considerations for synergistic biologic products

Combination therapies: IP considerations for synergistic biologic products

Perfect storm – four drivers behind the mRNA litigation wave

Perfect storm – four drivers behind the mRNA litigation wave

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

See All News
No items found.